Diversified Healthcare Trust
NASDAQ:DHC

Watchlist Manager
Diversified Healthcare Trust Logo
Diversified Healthcare Trust
NASDAQ:DHC
Watchlist
Price: 5.865 USD 0.95% Market Closed
Market Cap: $1.4B

Diversified Healthcare Trust
Investor Relations

Diversified Healthcare Trust is a real estate investment trust, which engages in the ownership of senior living communities, medical office buildings, and wellness centers. The company is headquartered in Newton, Massachusetts and currently employs 600 full-time employees. The firm owns medical office and life science properties, senior living communities, and other healthcare related properties throughout the United States. The firm's segments include Office Portfolio and SHOP. Its Office Portfolio segment consists of medical office properties leased to medical providers and other medical related businesses, as well as life science properties leased to biotech laboratories and other similar tenants. Its SHOP segment consists of managed senior living communities that provide short-term and long-term residential living and, in some instances, care and other services for residents where it pays fees to the operator to manage the communities for its account. Its portfolio consists of constructed commercial properties to operate as medical office space for physicians and other healthcare personnel, medical related fields, including clinics and life science or laboratory.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 4, 2025
AI Summary
Q3 2025

Revenue Growth: DHC reported Q3 revenue of $388.7 million, up 4% year-over-year, reflecting continued momentum in its operating segments.

SHOP Performance: Senior housing (SHOP) occupancy rose 210 basis points YoY to 81.5%, with RevPAR up 5.3%, but temporary labor costs tied to operator transitions weighed on NOI.

Operator Transitions: Transition of 116 AlerisLife-managed communities to new operators caused $5.1 million in elevated Q3 labor costs, expected to decrease to $1.5–$2 million in Q4.

Guidance Reaffirmed: Full-year 2025 SHOP NOI guidance of $132–$142 million and CapEx guidance of $140–$160 million were both reaffirmed.

Asset Sales Progress: Year-to-date, 44 properties sold for $396 million; further $237 million in sales under agreement, mostly expected to close by year-end.

Improved Liquidity: No significant debt maturities until 2028 after repaying 2026 bonds, with $351 million in liquidity at quarter-end.

Margin Headwinds: Temporary expense increases (labor, utilities) impacted quarterly margins, but management expects these pressures to ease after transitions complete.

Positive Outlook: Management highlighted a strong liquidity profile and expects margin expansion and cash flow growth as transitions finish and operational improvements take hold.

Key Financials
Revenue
$388.7 million
Adjusted EBITDAre
$62.9 million
Normalized FFO
$9.7 million or $0.04 per share
SHOP Occupancy
81.5%
SHOP NOI
$29.6 million
Same-property cash-based NOI
$62.6 million
G&A Expense
$12.8 million
CapEx
$43 million for the quarter
Liquidity
$351 million at quarter-end
Unrestricted Cash
$201 million
Revolving Credit Facility Availability
$150 million
Net Debt-to-Adjusted EBITDAre
10x
Net Debt-to-Adjusted EBITDAre (excluding transition expense)
9.3x
Medical Office and Life Science Consolidated Occupancy
86.6%
Asset Sales
$396 million year-to-date (44 properties); $237 million under agreement
Earnings Call Recording
Other Earnings Calls

Management

Mr. Adam David Portnoy
Managing Chair of the Board
No Bio Available
Mr. Matthew C. Brown CPA
CFO & Treasurer
No Bio Available
Mr. Christopher J. Bilotto
President, CEO & Managing Trustee
No Bio Available
Kevin Brady
Director of Investor Relations
No Bio Available
Mr. David M. Blackman
Director of Acquisition
No Bio Available
Ms. Jennifer Babbin Clark
Secretary
No Bio Available
Melissa Mccarthy
Manager of Investor Relations
No Bio Available

Contacts

Address
MASSACHUSETTS
Newton
C/O The Rmr Group, Two Newton Pl., 255 Wash. St., Ste. 300
Contacts
+16177968350.0
www.dhcreit.com